Quintrio
Home

SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

iSpecimen Inc. Common Stock

ISPC

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.

Last trade $0.5862
Day change -$0.0187 (-3.09%)
Day range $0.56 – $0.609
Volume 38,374
Market cap $2M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$1.51M
Price / earnings
—
Price / book
0.87×
Price / sales
3.24×
EV / sales
-6.23×
EV / EBITDA
0.35×

Profitability

Earnings per share
-$4.53
Return on assets
-154.47%
Return on equity
-657.69%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0×
Current ratio
0.82×
Quick ratio
0.82×
Cash ratio
0.81×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$7M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for ISPC, quarterly periods
Line itemQ2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024Q3 FY2024 Sep 30, 2024
Revenue$151.94K$156.01K$51.76K$106.59K$713.14K$1.06M$1.48M$2.66M
Cost of revenue$83.29K$84.41K$598.84K$204.59K$444.18K$657.28K$1.32M$1.55M
Gross profit$68.65K$71.6K-$547.08K-$98K$268.96K$400.23K$151.35K$1.11M
Selling, general and administrative$986.97K$2.22M$1.98M$2.56M$1.21M$1.11M$5.53M$2.28M
Research and development$327.74K$281.57K$31.84K$22.37K$635.4K$639.05K$117.57K$84.97K
Total operating expenses$1.43M$2.61M$2.14M$2.73M$2.09M$2.04M$5.99M$2.81M
Operating income-$1.36M-$2.54M-$2.69M-$2.83M-$1.82M-$1.64M-$5.84M-$1.71M
Interest expense$0-$1.25K-$7.97K-$2$9.62K-$20.49K-$203.77K-$7.36K
Income before taxes-$1.36M-$2.28M-$5M-$2.78M-$1.05M-$1.66M-$6.05M-$1.44M
Income taxes$0$0$0$0$0$0$0$0
Net income-$1.36M-$2.28M-$5M-$2.78M-$1.05M-$1.66M-$6.05M-$1.44M
Net income attributable to common shareholders-$1.36M-$2.28M-$5M-$2.78M-$1.05M-$1.66M-$6.05M-$1.44M
EBITDA-$1.16M-$2.4M-$2.28M-$2.37M-$1.39M-$1.21M-$5.29M-$1.16M
Basic earnings per share-$0.98-$6.66-$25.81-$19.20-$16.78-$28.55-$213.52-$84.00
Diluted earnings per share-$0.98-$6.66-$25.81-$19.20-$16.78-$28.55-$213.52-$84.00

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

E.F. Hutton & Co. Acts as Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen

E.F. Hutton & Co. served as exclusive placement agent for iSpecimen Inc.'s $5 million public offering. This marks the third capital markets engagement between the two firms since December 2025. The capital will support iSpecimen's strategic priorities including liability repayment, potential acquisitions, marketing initiatives, and general corporate purposes.

GlobeNewswire Inc.

E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement

E.F. Hutton & Co. acted as exclusive placement agent for iSpecimen Inc.'s $2.5 million private placement, which closed on May 11, 2026. This marks the second financing transaction between the two companies in six months, following a $5.5 million placement in December 2025. iSpecimen operates an online marketplace connecting researchers with biospecimen providers for medical research.

GlobeNewswire Inc.

iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement

iSpecimen Inc. (Nasdaq: ISPC) announced a private placement offering of approximately $2.5 million in gross proceeds. The company will issue 488,281 shares at $5.12 per share, with net proceeds intended for working capital and marketing expenses. The offering is expected to close on May 11, 2026, subject to customary closing conditions and requires stockholder approval under Nasdaq Listing Rules.

Benzinga

iSpecimen Is Trending Overnight — Here's Why ISPC Stock Surged 56% In The After-Hours Session

iSpecimen Inc. (NASDAQ: ISPC) shares surged 56.19% in after-hours trading to $0.20 following the announcement of a direct supplier-to-customer shipping overhaul that reduces domestic transit times by 70-85%, cutting delivery from 7-14 days to 1-2 days. The company also expanded rare specimen sourcing partnerships across Europe. However, the stock remains down 90.84% over the past 12 months and closed the regular session at $0.13.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Apr 28, 20261-for-40reverse split
Sep 16, 20241-for-20reverse split